Ftse Mib
34.478,84
0,05%
DAX
18.691,32
0,05%
S&P 500
5.310,87
0,07%
NASDAQ
16.943,95
0,85%
Bitcoin
67.835,55
-1,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Pivotal Therapeutics Inc (CE) (PVTTF) Pivotal Therapeutics Inc (CE) (PVTTF) Notizie

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PVTTF
DataOraFonteTitoloSimboloCompagnia
05/05/201423:22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
07/10/201322:39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201314:54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201319:49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201319:46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
05/09/201318:45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321:24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201321:11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306:44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201306:33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/05/201318:34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
07/05/201316:55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/05/201318:07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
01/05/201300:08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201302:38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
16/04/201321:00ZacksPivotal Progresses with Vascazen - Analyst BlogUSOTC:PVTTFPivotal Therapeutics Inc (CE)
09/04/201314:45OTC MarketsPivotal Therapeutics VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at t...USOTC:PVTTFPivotal Therapeutics Inc (CE)
06/03/201318:42OTC MarketsPivotal Therapeutics Exhibiting at the American College of Cardiology's 62nd Annual Scientific Session and EXPOUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/11/201200:12OTC MarketsHome Country News ReleaseUSOTC:PVTTFPivotal Therapeutics Inc (CE)
28/05/201222:31GlobeNewswire Inc.Pivotal Therapeutics Reports 1st Quarter 2012 ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PVTTF

La tua Cronologia

USOTC
QTHLF
Quantum Healthcare (CE)
ASX
ATOM
Global X Management AUS
BIT
P1YLC4
NLBNPIT1YLC4 20240920 11
BIT
S31898
Societe Generale Effekten
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network